1Matsumoto A, Tanaka E, Morita S, et al. Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection[J]. J Gastroenterol,2012,47(9) : 1006-1013.
2Shiota G, Oyama K, Udagawa A, et al. Partial analysis of hepatitis B virus DNA from hepatocellular carcinoma showing negative hepati- tis B virus surface antigen: an analysis of two Japanese cases [J]. Hepatogastroenterology, 2009,56 ( 94-95 ) : 1516-1520.
3Bian T, Yan H, Shen L, et al. Change of hepatitis B large surface an- tigen variants after 13 years universal vaccination program in China [J]. J Virol,2013,7(22):12196-12206.
5He C, Nomura F, Itoga S, et al. Prevalence of vaccine-induced es- cape mutants of hepatitis B vires in the adult population in China:a prospective study in 176 restaurant employees [J]. Gastroenterol Hepatol, 2001,16(12) : 1373-1377.
6Tong M J, Nguyen MO, Tong LT, et al. Development of hepatocellu- lar carcinoma after seroclearance of hepatitis B surface antigen [J]. Clin Gastroenterol Hepatol, 2009,7 (8) : 889-893.
2wBonilla Guerrero R, Roberts L R. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellu- lar carcinoma[ J ]. J Hepatol, 2005,42:760-777.
3Murakami Y, Minami M, Daimon Y, et al. Hepatitis B vi- rus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen[J]. J Med Virol, 2004,72:203-214.
4Murakami Y, Saigo K, Takashima H, et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatoeellular carcinomas[ J]. Gut, 2005,54 : 1162- 1168.
5Buckwold V E, Xu Z, Chen M, et al. Effects of a naturally occuring mutation in the hepatitis B virus basal core promot-er on precore gene expression and viral replication [ J ]. J Virol, 1996,70 : 5845- 5851.
6Chou Y C, Yu M W, Wu C F, et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma [ J]. Gut, 2008,57:91--97.
7Yuen M F, Tanaka Y, Shinkai N, et al. Risk for hepato- cellular carcinoma with respect to hepatitis B virus geno- types B/C, specific mutations of enhancer II./core promot- er/precore regions and HBV DNA levels [ J ]. Gut, 2008, 57:98-102.
8Minami M, Poussin K, Br6chot C, et al. A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome[ J]. Genomics, 1995,29:403-408.
9Wang Y, Lau S H, Sham J S, et al. Characterization of HBV integrants in 14 hepatocellular carcinomas: association of tluncated X gene and hepatocellular carcinogenesis [ J ]. Oncogene, 2004,23 : 142-148.
10Paterlini-Brechot P, Saigo K, Murakami Y, et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomer- ase gene[ J ]. Oncogene, 2003,22:3911- 3916.
